NovaBridge Biosciences
NBPNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $158.54M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.26$5.33
- Volume (live)
- -
- Avg. volume (3M)
- 599.77K
NovaBridge Biosciences (NBP) Stock Price & Financial Analysis
NovaBridge Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.26 - $1.38 |
|---|---|
| 52-Week High | $5.33 |
| 52-Week Low | $1.26 |
| Open | $1.31 |
| Volume (last close) | 558.73K |
| Average Volume (3M) | 599.77K |
| 50-Day MA | $1.62 |
|---|---|
| 200-Day MA | $2.29 |
| 1-Year Change | −69.70% |
| Market Cap | 158.54M |
|---|---|
| Shares Outstanding | 115.72M |
| Price to Book (P/B) | 0.79 |
| EV/EBITDA | 0.26 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
NovaBridge Biosciences at a Glance
As of the Oct 23, 2026 close, NovaBridge Biosciences (NBP) has a market capitalization of $158.54M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $190.64M in cash and securities against $4.46M of debt, a net cash position of $186.18M.
NovaBridge Biosciences does not currently pay a dividend.
The share price is down 69.7% over the past year. At $1.37 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $1.26 to $5.33, below its 200-day moving average of $2.29.
Frequently Asked Questions About NovaBridge Biosciences
What is the current stock price for NBP?
As of the Oct 23, 2026 close, NBP stock trades at $1.37. The 52-week range is $1.26–$5.33, with a day range of $1.26–$1.38.
What is the P/E ratio for NBP?
The P/E ratio (Price-to-Earnings) for NBP is shown in the Key Statistics section. This valuation metric helps compare NovaBridge Biosciences to industry peers.
Does NBP pay dividends?
NovaBridge Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NBP?
Analyst ratings and recommendations for NBP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NBP?
As of the Oct 23, 2026 close, NovaBridge Biosciences's market capitalization is $158.5M, classifying it as a micro-cap company. NovaBridge Biosciences operates in the Healthcare sector within the Biotechnology industry.